Minimize Uncertainty – Make Informed Decisions – Succeed

Onco_background

Oncology Today—March 23, 2026

March 23, 2026Telix Pharmaceuticals,PrimeBody ADC Platform,NovaBridge,Remix Therapeutics,astrazeneca,Givastomig,REM-422,BioPharma and Tech News,CLDN18.2,Colorectal Cancer,Candel Therapeutics,gastric cancer,CAN-2409,Imfinzi,Lantheus,Daiichi Sankyo,LNTH-2501,adenoid cystic carcinoma,Dizal,neuroendocrine tumors,ZEGFROVY,Oncology News,EGFR Exon 20 Insertion NSCLC,Non-small cell lung cancer,CytomX Therapeutics,Non-muscle invasive bladder cancer,Varsetatug Masetecan,gastroesophageal junction cancer,TLX101-Px,ImmunityBio,Glioma ImagingANKTIVA,Voro Therapeutics

This week’s Oncology update highlights EU regulatory expansion, late-stage…

by LucidQuest

Artificial_Intelligence

AI in Healthcare and Digital Health Today—March 23, 2026

March 23, 2026Perplexity Health,Acute Leukemia,cell and gene therapy,CVS Pharmacy AI Screening,BioPharma and Tech News,NHS England,AI in Healthcare and Digital Health,inflammatory bowel disease,Acute ischemic stroke,Office For Life Sciences,University Of Leicester,Centre For Chronic Disease Control,Ayushman Bharat Digital Health Mission,Verily Health,Health UniverseUPATHLN,Fitbit Personal Health Coach

This week’s AI in Healthcare and Digital Health update highlights…

by Timos Papagatsias

Hematology

Hematology Today—March 23, 2026

March 23, 2026gene therapy manufacturing,CSL,FDA,Knight Therapeutics,BioPharma and Tech News,Belief BioMed,hemophilia b,BBM-H901,nivolumab,BBM-H803,Hodgkin Lymphoma,HMPL-760,follicular lymphoma,Annamycin,Moleculin,Acute Myeloid Leukemia,Hemgenix,Hematology News,Diffuse large B-cell lymphomaHUTCHMED,Minjuvi

This week’s Hematology update highlights hemophilia gene therapy supply…

by LucidQuest

Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Dizal announces Zegfrovy (sunvozertinib) positive results in EGFR Exon20ins NSCLC

March 23, 2026clinical trials,market access,fda approval,lung cancer,biopharma,Lucid Diligence Brief,regulatory affairs,EGFR Exon 20,oncology diligence,Dizal PharmaceuticalNSCLC treatments

Lucid Diligence Brief: Dizal announces Zegfrovy (sunvozertinib) positive…

by Timos Papagatsias

Lucid Diligence Brief - Tech

Lucid Diligence Brief: Fauna Bio obesity target designation with Lilly

March 22, 2026biotech,obesity,Eli Lilly,Lucid Diligence Brief,payer access,metabolic disease,diligence,AI drug discovery,target discovery,Fauna Biopreclinical

Lucid Diligence Brief: Fauna Bio obesity target designation with Lilly…

by Timos Papagatsias

Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Novartis to acquire Pikavation Therapeutics from Synnovation

March 21, 2026clinical trials,novartis,breast cancer,precision oncology,Lucid Diligence Brief,diligence,Synnovation,SNV4818,PI3K alpha,PIK3CA,oncology M&A,endocrine therapyCDK4/6

Lucid Diligence Brief: Novartis to acquire Pikavation Therapeutics from…

by Timos Papagatsias

Public_Health

Public Health Today—March 20, 2026

March 20, 2026medical cannabis,mental health treatment,Infectious Diseases,sleeping sickness,multiple sclerosis,precision medicine,global health,immunotherapy,BioPharma and Tech News,CAR T Therapy,Cardiovascular Risk,GLP-1 Receptor Agonists,Public Health News,obesity management,weight loss durabilityhypertension guidelines,cholesterol management

This weekly public health update highlights recent developments across clinical…

by LucidQuest

Vaccines

Vaccines Today—March 20, 2026

March 20, 2026Tetanus,Diphtheria,dengue,EVX-01,gsk,Na-GST 1/Al-CpG,Arexvy,Hookworm Infection,BioPharma and Tech News,Elaris,Glioblastoma,VLA84,Valneva,Clostridioides Difficile Infection,Evaxion,Vaccine news,respiratory syncytial virus,Advanced melanoma,Butantan Institute,Butantan-DVStablepharma,SPVX02

This week’s Vaccines Research update highlights regulatory expansions,…

by LucidQuest

Respiratory

Respiratory Today—March 20, 2026

March 20, 2026INI-2004,Allergic Rhinitis,BioPharma and Tech News,Baseimmune,BioVersys,YOLT-202,SK Bioscience,Eupraxia Pharmaceuticals,Idiopathic Pulmonary Fibrosis,EP-104GI,Respiratory News,Eosinophilic Esophagitis,chronic obstructive pulmonary disease,CS014,Pulmonary tuberculosis,Pulmonary Hypertension Associated With Interstitial Lung Disease,Alpha-1 antitrypsin deficiency,RSM01,Cereno Scientific,Respiratory Syncytial Virus Prevention,Nuance Pharma,Ohtuvayre,YolTech TherapeuticsAlpibectir-Ethionamide,Inimmune

This week’s Respiratory, Research update highlights regulatory progress,…

by LucidQuest

Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Kupando adds €10 million to its Series A for Toll-like receptor assets

March 20, 2026biotech,Oncology,clinical trials,AMR,immuno-oncology,Lucid Diligence Brief,diligence,venture financing,innate immunity,trained immunity,TLR4,TLR7Germany biotech

Lucid Diligence Brief: Kupando adds €10 million to its Series A for Toll-like…

by Timos Papagatsias

Cardiovascular

Cardiovascular Today—March 19, 2026

March 19, 2026Acute Ischaemic Stroke,RiHEART,POLY-ACS,Pre-MIRACLE2,BioPharma and Tech News,Polypill,HEART FAILURE,Acute Coronary Syndrome,Parkinson's Disease,Johnson & Johnson MedTech,Ischemic Stroke,CEREGLIDE 42,Cardiovascular News,CEREGLIDE 57,Asundexian,INNERGLIDE 7,secondary stroke prevention,Verve Medical,Percutaneous coronary intervention,Renal Pelvic Denervation,CathWorks,Uncontrolled Hypertension,FFRangio,Emboline,MIRACLE2,Emboliner,Out Of Hospital Cardiac Arrest,Sumitomo Pharma,Route 92 Medical,AMCHEPRYSUMMIT RISE,Cuorips

This week’s Cardiovascular update highlights clinical trial progress, product…

by LucidQuest

Rare Disease news

Rare Diseases Today—March 19, 2026

March 19, 2026LIVMARLI,Cholestatic Pruritus,BioPharma and Tech News,Zenith Genomics,Netherton syndrome,Rare Disease Diagnosis,Ultragenyx,QRX003,Sentynl,DTX301,Rare Disease News,Ornithine Transcarbamylase Deficiency,OpenEvidence,Leucovorin,Mirum Pharmaceuticals,Cerebral Folate Deficiency,Otsuka,Progerinin,Natera,Aro Biotherapeutics,Phenylketonuria,ABX1100,Quoin Pharmaceuticals,Late-Onset Pompe Disease,National Organization for Rare DisordersHutchinson-Gilford Progeria syndrome,Repinatrabit

This week’s Rare Diseases update highlights regulatory momentum, clinical…

by LucidQuest

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required
You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.